ClinVar Miner

Submissions for variant NM_001904.4(CTNNB1):c.1494dup (p.His499fs)

dbSNP: rs1553631896
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000627529 SCV000705263 pathogenic not provided 2017-04-14 criteria provided, single submitter clinical testing
GeneDx RCV000627529 SCV000748529 pathogenic not provided 2018-04-04 criteria provided, single submitter clinical testing The c.1494dupA variant in the CTNNB1 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.1494dupA variant causes a frameshift starting with codon Histidine 499, changes this amino acid to aThreonine residue, and creates a premature Stop codon at position 31 of the new reading frame, denoted p.His499ThrfsX31. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.1494dupA variant is not observed in large population cohorts (Lek et al., 2016).
Mendelics RCV000987260 SCV001136510 pathogenic Hepatocellular carcinoma 2019-05-28 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000627529 SCV002236521 pathogenic not provided 2022-11-01 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 499655). This premature translational stop signal has been observed in individual(s) with clinical features of CTNNB1-related conditions (PMID: 29682453). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.His499Thrfs*31) in the CTNNB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CTNNB1 are known to be pathogenic (PMID: 23033978, 24614104, 25326669, 26350204, 28575650).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.